Evidence map›Paper›PMID 33815532›Full record

ArticlePolish journal of microbiology2021

Clonal Dissemination of KPC-2, VIM-1, OXA-48-Producing

Dorota Ochońska, Hanna Klamińska-Cebula, Anna Dobrut, Małgorzata Bulanda, Monika Brzychczy-Włoch

Abstract read
In one paragraph

Article in Polish journal of microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Infection and drug resistance · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Evolution of Antibiotic Resistance inJournal of clinical medicine · 2023
    Article
  7. Occurrence and Characteristics of Carbapenem-ResistantPathogens (Basel, Switzerland) · 2022
    Article
  8. Surveillance Study ofAntibiotics (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dorota OchońskaDepartment of Molecular Medical Microbiology, Chair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
Hanna Klamińska-CebulaDepartment of Bacteriology, Leszek Giec Upper-Silesian Medical Centre of the Silesian Medical University in Katowice, Katowice, Poland.
Anna DobrutDepartment of Molecular Medical Microbiology, Chair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
Małgorzata BulandaDepartment of Molecular Medical Microbiology, Chair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
Monika Brzychczy-WłochDepartment of Molecular Medical Microbiology, Chair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

AgedAged, 80 and overAnti-Bacterial Agentsbeta-LactamasesCross InfectionDrug Resistance, Multiple, BacterialFecesFemaleHumansKlebsiella InfectionsKlebsiella pneumoniaeMaleMicrobial Sensitivity TestsMiddle AgedMultilocus Sequence TypingPolandAnti-Bacterial Agentsbeta-lactamase KPC-2, Klebsiella pneumoniaebeta-Lactamasesbeta-lactamase VIM-12, Klebsiella pneumoniaeoxacillinasecarbapenem-resistant Klebsiella pneumoniaeclonal disseminationhospitalMLSTPFGE

Identifiers

PMID33815532
PMCPMC8008758

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.